Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.32 USD | +7.17% | +12.27% | +12.62% |
Apr. 24 | Avid Bioservices, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Mammalian Cell Culture
84.0
%
| 99 | 83.0 % | 125 | 84.0 % | +26.32% |
Process Development
16.0
%
| 20 | 17.0 % | 24 | 16.0 % | +17.40% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 120 | 100.0 % | 149 | 100.0 % | +24.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 20-07-29 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 18-07-31 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 98-12-31 |
Richard Richieri
COO | Chief Operating Officer | 59 | 19-10-08 |
Richard Hancock
BRD | Director/Board Member | 65 | 17-11-26 |
Oksana Lukash
HRO | Human Resources Officer | - | 22-11-15 |
Michael Alston
PRN | Corporate Officer/Principal | - | 18-12-31 |
Michael Faughnan
PRN | Corporate Officer/Principal | - | - |
Elie Hanania
PRN | Corporate Officer/Principal | - | 21-11-03 |
Corporate Officer/Principal | - | 21-10-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 59 | 17-11-26 |
Joseph Carleone
CHM | Chairman | 78 | 17-11-26 |
Catherine Mackey
BRD | Director/Board Member | 68 | 19-07-24 |
Nicholas Green
CEO | Chief Executive Officer | 60 | 20-07-29 |
Esther Alegria
BRD | Director/Board Member | 66 | 21-06-27 |
Jeanne A. Thoma
BRD | Director/Board Member | 64 | 20-12-02 |
Richard Hancock
BRD | Director/Board Member | 65 | 17-11-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,239,238 | 62,540,622 ( 98.90 %) | 0 | 98.90 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.62% | 465M | |
-4.68% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+58.56% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+5.17% | 8.75B |
- Stock Market
- Equities
- CDMO Stock
- Company Avid Bioservices, Inc.